Gilead Sciences to Acquire Kite Pharma for $11.9 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Gilead Sciences (GILD) Trades Near Session High, Up 3%
August 30, 2017 10:14 AM EDTGilead Sciences (NASDAQ: GILD) Trades Near Session High, Up 3%
... MoreGilead Sciences (GILD) PT Raised to $85 at Credit Suisse Amid Kite Deal
August 29, 2017 6:05 AM EDTCredit Suisse analyst Alethia Young raised her price target on Gilead Sciences (NASDAQ: GILD) to $85.00 (from $79.00) while maintaining a Outperform rating following the acquisition of Kite Pharma.
Young said the deal "marks the beginning of a new chapter." She said at the... More
Baird 'Incrementally Negative' on Gilead Sciences (GILD) Deal for Kite
August 28, 2017 11:16 AM EDTBaird analyst Brian Skorney said he was "incrementally negative" Gilead Sciences' (NASDAQ: GILD) acquisition of Kite Pharma (NASDAQ: KITE).
Skorney said while the immediate comparisons will be made to its acquisition of Pharmasset,... More
Kite Pharma (KITE) Set to Resume Trading t 7:30AM ET
August 28, 2017 7:07 AM EDTKite Pharma (NASDAQ: KITE) set to resume trading at 7:30AM ET after it agreed to be acquired by Gilead for $180.00 per share in cash.
... MoreKite Pharma (KITE) to Resume Trading at 7:30 AM ET
August 28, 2017 7:07 AM EDTKite Pharma (NASDAQ: KITE) to Resume Trading at 7:30 AM ET
... More